Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
No Growth Hormone-Related Side Effects Critically, AOD-9604 did not produce any of the adverse effects associated with growth hormone therapy
Kannt, A
Fewer DPCs means weaker growth signals, which means thinner, shorter hair
The most common side effects are mild and may include pain or redness at the injection site, mild diarrhea, nausea, or a feeling of swelling all over the body
Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each These subcutaneous examples come from informal research discussions
